Open AccessAberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer
Author(s) -
Alex J. Eustace,
Min Jie Lee,
Grace Colley,
Jack Roban,
Tim Downing,
Paul Buchanan
Publication year - 2022
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2022.41
Subject(s) - pi3k/akt/mtor pathway , cancer research , carcinogenesis , breast cancer , triple negative breast cancer , protein kinase b , targeted therapy , biology , calcium signaling , cancer , calcium channel , signal transduction , bioinformatics , medicine , calcium , genetics